Navigation Links
Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
Date:2/12/2009

ts regarding Vermillion's plans, objectives, expectations and intentions. These forward-looking statements are based on Vermillion's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. In order to comply with the terms of the safe harbor, Vermillion notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. There are no guarantees that Vermillion will succeed in its efforts to commercialize any of its products or that it will improve diagnosis and treatment of ovarian cancer in 2009 or during any other period of time. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty in obtaining intellectual property protection for inventions made by Vermillion; (2) unproven ability of Vermillion to discover, develop, and commercialize diagnostic products for the treatment of ovarian cancer based on findings from its disease association studies; (3) unproven ability of Vermillion to discover or identify new protein biomarkers and use such information to develop diagnostic products for the treatment of ovarian cancer; (4) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its diagnostic products for the treatment of ovarian cancer; (5) uncertainty of market acceptance of its diagnostic products for the treatment of ovarian cancer, including the risk that its products will not be competitive with products offered by other companies, or that users will not be entitled to receive adequate reimbursement for its products from third party payors such as private insurance companies and government insurance plans; and (6) other factors that might be described from time to time in Vermillion's filings with the Securities and Exchange Commission. All information in this
'/>"/>
SOURCE Vermillion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vermillion Announces Receipt of NASDAQ Panel Decision
2. Vermillion and Stanford Scientists Receive Best Research Award From the PAD Coalition
3. Vermillion Retains ThinkPanmure to Assist in the Evaluation of Potential Strategic Alternatives
4. Vermillion to Host Live Roundtable Discussion With Principal Investigator of OVA1(TM) Submission
5. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
6. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
7. Vermillion Announces Appointment of John Hamilton to Board of Directors
8. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
9. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
10. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
11. Vermillion Announces Effectiveness of Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and ... at the liquid/air interface. The NeedleProbes’ cylindrical geometry enables ... rate and viscosity - all in a single force distance ... ... 2009 -- New, constant diameter NeedleProbes are enabling ...
(Date:12/15/2009)... LONDON, Dec. 15 Thomson ... Pharma ® has become the first drug pipeline ... and outcome information. This highly anticipated new content ... this month. ,, Thomson Pharma ... from registries, publications, press releases, conferences, and other ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ... collaboration with The Scripps Research Institute ("Scripps") by ... the genome of Dyadic,s patented and proprietary C1 ... of the successful relationship between the two organizations ... Scripps to annotate the C1 genome for the ...
(Date:12/14/2009)... SAN CARLOS, Calif., Dec. 14 Nektar ... Dennis Winger has been appointed to serve on ... highly-respected biopharmaceutical industry leader with over 35 years ... strategy. ,, "Dennis brings to Nektar extensive industry ... evolution," said Howard W. Robin, President and CEO ...
Breaking Biology Technology:New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... Qian Gao, Kris Simonyi, and Claudia Suen, Bio-Rad Laboratories, Inc.,2000 Alfred Nobel Drive, Hercules, ... Introduction , ... proteins within a variety of cell culture and ... new techniques that apply a sandwich antibody capture approach , ...
... , , , , AquaPure RNA Isolation ... , Method , ... ml cell lysis solution to an Oak Ridge centrifuge , tube (or ... (e.g., cerebrospinal fluid, plasma, saliva, serum, sputum, synovial fluid, , urine, whole ...
... , HaiYan Jiang a,e , Robert J. Hickey a-e, h ... W. Wills a, e , SuHua Han a,e , Timothy D. Tom a-g , YueTong ... a-e,+ , (a) Department of Pharmacology and Experimental Therapeutics , ... (d) Program in Toxicology (e) University of Maryland School ...
Other Biology Technology:Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 2Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 3Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 4Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 5Total RNA Isolation From 500 l Body Fluid 2Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 2Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 3Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 4Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 5Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 6Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 7Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 8Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 9
(Date:12/14/2009)... The most comprehensive study to date of the proteins ... may provide important clues to how similar regeneration could ... School of Science at Indiana University-Purdue University Indianapolis and ... limbs of axolotls, a type of salamander that has ... level of amputation, with the hope that this knowledge ...
(Date:12/14/2009)... MODA Technology Partners, a global software ... product testing for the Pharmaceutical industry, today announced ... third generation mobile data acquisition platform. The latest ... automate their regulated manufacturing processes. ,, MODA ... Fully-Configurable Test Methods: Each test method ...
(Date:12/13/2009)... that are associated with the health of the human ... scientists from 63 centres in Europe and Australia sheds ... , The new findings provide hope for better treatment ... and asthma. In the past it has been difficult ... affect the health of the lung are not completely ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New genes for lung disease discovered 2Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 1Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 2Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 3Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 4Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 5Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 1Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 2Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 3Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 4Symmetry Medical to Present at JMP Securities Healthcare Focus Conference 58257 1Symmetry Medical to Present at JMP Securities Healthcare Focus Conference 58257 2
... the first globally co-ordinated plan for the planet,s gravest ... the world this weekend, a new report sets out ... infectious diseases such as avian flu. , Ministers of ... prepare for, and respond to, the threat of avian ...
... cause of death in all cancer patients continues to be ... treatment in which chemicals are used to kill cells. ... on cancer cells reports that ingesting apigenin a naturally ... cancer cells, response to chemotherapy. , Xuan Liu , ...
... Health are testing an investigational treatment to learn if ... immediately help them breathe more easily. Destruction of lung ... overinflated with air that cannot escape. The holes, kept ... procedure, could relieve the hyperinflation of the lungs, allowing ...
Other Biology News:Avian flu threat: New approach needed 2How eating fruit and vegetables can improve cancer patients' response to chemotherapy 2National Jewish Health researchers evaluating treatment to help emphysema sufferers breathe easier 2
Request Info...
MOUSE ANTI SIMIAN VIRUS 5 Immunogen: Simian virus 5...
MOUSE ANTI SIMIAN VIRUS 5:FITC Immunogen: Simian virus 5...
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
Biology Products: